Need professional-grade analysis? Visit stockanalysis.com
$147.99M
N/A
13
N/A
Price Chart
Risk-Adjusted Performance
Also Listed On
Immunovia publ AB (IMMNOV) Price Performance
Immunovia publ AB (IMMNOV) trades on Nasdaq Stockholm in SEK. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at SEK0.20, down 5.21% from the previous close.
Over the past year, IMMNOV has traded between a low of SEK0.16 and a high of SEK0.75. The stock has lost 3.3% over this period. It is currently 73.2% below its 52-week high.
Immunovia publ AB has a market capitalization of $147.99M.
About Immunovia publ AB
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Compare Immunovia publ AB
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- Nasdaq Stockholm
- Currency
- SEK
- Country
- Sweden
Financial Metrics
- Revenue (TTM)
- $685,000
- EBITDA
- $-80,414,000
- Profit Margin
- -21301.46%
- EPS (TTM)
- -0.42
- Book Value
- 0.10
Technical Indicators
- 52 Week High
- SEK 0.75
- 52 Week Low
- SEK 0.15
- 50 Day MA
- SEK 0.18
- 200 Day MA
- SEK 0.30
- Beta
- 2.63
Valuation
- Trailing P/E
- N/A
- Forward P/E
- N/A
- Price/Sales
- 216.04
- Price/Book
- 2.44
- Enterprise Value
- $81.47M